{"id":468837,"date":"2021-03-31T11:50:22","date_gmt":"2021-03-31T15:50:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=468837"},"modified":"2021-03-31T11:50:22","modified_gmt":"2021-03-31T15:50:22","slug":"zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/","title":{"rendered":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  31, 2021  (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>To join the class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VxtEF-AODv8qV_RYNls2l4aPTVORgQ6Xvj4Dibk9vkjP5ffay_DYPe9mKboRBIQNG-o7gGVftp6Yfqufh8pB8HIgUKtF86zu0XKof_IscvSuh7cdh0udz0jM4Y3rH6JA_rdkQTrz0N-KWgEioO3tDurnB6dV7EXvEdPdnwX1v84pDrDhn-46k9e2YEXnR1o4jkD0vG741LB18LSHClHkhPDW3deIU7WiFspE_p-jJEc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665<\/a> or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O-FX4JSqHJOSPXB0ybAXSVxgpxJtko4Dv76oeXKf6hSIcs5XkKu1PszRS2L7UO6PjsGmaOnehvONk-3b19IcBywg-flPqJcus6S_zfOm8u0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a>\u00a0for information on the class action.<\/p>\n<p>\u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VxtEF-AODv8qV_RYNls2l4aPTVORgQ6Xvj4Dibk9vkjP5ffay_DYPe9mKboRBIQNG-o7gGVftp6Yfqufh8pB8HIgUKtF86zu0XKof_IscvQ3502WZkWlUPLcl1W7YwWcOzgSOLB4JckHdKlIlIud1Ghw472Tlb6YR1oLlGSHwzfHLY_p8dXC4u8acOHpCk2SwaUrp7K36dzGcNgDRkw9-KFm1o-AL0PITYRE7mbjfKs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665<\/a><\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>May 17, 2021 DEADLINE.<\/strong>\u00a0A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0<\/p>\n<p>According to the lawsuit, defendants throughout the Class Period &#8211; while touting Leronlimab as a potential treatment for COVID-19 to pump up the CytoDyn\u2019s stock price, company executives aggressively sold their shares. The complaint also alleges that CytoDyn engaged in a wrongful scheme whereby Iliad Research and Trading L.P. and other entities related to Iliad\u2019s principal John Fife operated as an unregistered securities dealer for CytoDyn. On this news, the Company\u2019s share price fell $1.14 per share, or 28%, to close at $2.91 on March 8, 2021. On March 9, 2021, CytoDyn shares dropped an additional 19% to close at $2.35, thereby injuring investors further.<\/p>\n<p>Lead plaintiff status is not required to seek compensation.\u00a0 You may retain counsel of your choice.\u00a0 You may remain an absent class member and take no action at this time.<\/p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Zhang Investor Law P.C.<br \/>99 Wall Street, Suite 232<br \/>New York, New York 10005<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O-FX4JSqHJOSPXB0ybAXSVxgpxJtko4Dv76oeXKf6hSQwAclMI5GK6hQlYbkQDz-40sL6McKwqGDS5WcKfXy6ECbJKaua4mrpfKAesop4pg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a><br \/>tel: (800) 991-3756<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b5655e43-1597-4b9d-b48c-59f45cd358e7\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 If you wish to serve as lead plaintiff, you must move the Court before the May 17, 2021 DEADLINE.\u00a0A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period &#8211; while touting Leronlimab as a potential treatment for COVID-19 to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-468837","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 If you wish to serve as lead plaintiff, you must move the Court before the May 17, 2021 DEADLINE.\u00a0A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period &#8211; while touting Leronlimab as a potential treatment for COVID-19 to &hellip; Continue reading &quot;Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-31T15:50:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY\",\"datePublished\":\"2021-03-31T15:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/\",\"name\":\"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\",\"datePublished\":\"2021-03-31T15:50:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/","og_locale":"en_US","og_type":"article","og_title":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk","og_description":"NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=cytodyn-inc&amp;id=2665 If you wish to serve as lead plaintiff, you must move the Court before the May 17, 2021 DEADLINE.\u00a0A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period &#8211; while touting Leronlimab as a potential treatment for COVID-19 to &hellip; Continue reading \"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-31T15:50:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY","datePublished":"2021-03-31T15:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/","name":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==","datePublished":"2021-03-31T15:50:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwOTU0MiM0MTAwNDcwIzUwMDA1MzY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-cytodyn-inc-cydy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against CytoDyn, Inc. \u2013 CYDY"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/468837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=468837"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/468837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=468837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=468837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=468837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}